I am a clinical pathologist with additional board certification in medical microbiology. As a clinical pathologist, my areas of expertise include laboratory hematology, coagulation, and microbiology. I am particularly interested in applying new technologies in the microbiology laboratory. New approaches, such as Matrix-Assisted Laser Desorption/Ionization-Time of Flight, and molecular methods like next-generation sequencing can shorten the time it takes to get test results. They can also provide more accurate organism identification and more effectively guide treatment decisions.
Clinical microbiology has been undergoing a technological revolution over the past five to 10 years, and it is exciting to see advances such as automation that help streamline workflows. I am fortunate to be involved in implementing these new technologies and will continue to look for novel approaches for diagnosing infections and providing meaningful antimicrobial susceptibility results.
An important aspect of my career is teaching. I value passing on my knowledge and experience to all levels of trainees from medical technologists to medical students, residents, and fellows. I find that I often learn from teaching activities whether it is through questions posed by trainees or by updating my knowledge on a topic.
As Vice Chair for Clinical Integration in the Department of Laboratory Medicine, one of my primary roles is to work with the clinical services as part of the multidisciplinary diagnostic management teams to provide expertise in laboratory testing. In this role, I work with clinicians throughout the institution to improve laboratory diagnostic algorithms, discuss performance characteristics of different tests, and understand the priorities of testing for patient care in different settings and clinical scenarios. Through these activities in clinical care, laboratory innovation, and teaching, I support the mission of Memorial Sloan Kettering and strive to advance the field of laboratory medicine.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Lauren McVoy discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at email@example.com.